Who Benefits From 5 Years of Extended Endocrine Therapy? ...Middle East

News by : (Medscape) -
MammaPrint genomic testing suggests that only patients with low-risk, not ultra-low-risk or high-risk, breast cancer benefit from 5 years of extended endocrine therapy. Medscape Medical News

Hence then, the article about who benefits from 5 years of extended endocrine therapy was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Who Benefits From 5 Years of Extended Endocrine Therapy? )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار